536 related articles for article (PubMed ID: 11978337)
1. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies.
Black GF; Weir RE; Floyd S; Bliss L; Warndorff DK; Crampin AC; Ngwira B; Sichali L; Nazareth B; Blackwell JM; Branson K; Chaguluka SD; Donovan L; Jarman E; King E; Fine PE; Dockrell HM
Lancet; 2002 Apr; 359(9315):1393-401. PubMed ID: 11978337
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of Danish-SSI 1331 BCG vaccine in the UK: comparison with Glaxo-Evans 1077 BCG vaccine.
Gorak-Stolinska P; Weir RE; Floyd S; Lalor MK; Stenson S; Branson K; Blitz R; Luke S; Nazareth B; Ben-Smith A; Fine PE; Dockrell HM
Vaccine; 2006 Jul; 24(29-30):5726-33. PubMed ID: 16723176
[TBL] [Abstract][Full Text] [Related]
3. Relationship between IFN-gamma and skin test responsiveness to Mycobacterium tuberculosis PPD in healthy, non-BCG-vaccinated young adults in Northern Malawi.
Black GF; Fine PEM ; Warndorff DK; Floyd S; Weir RE; Blackwell JM; Bliss L; Sichali L; Mwaungulu L; Chaguluka S; Jarman E; Ngwira B; Dockrell HM
Int J Tuberc Lung Dis; 2001 Jul; 5(7):664-72. PubMed ID: 11467373
[TBL] [Abstract][Full Text] [Related]
4. The influence of previous exposure to environmental mycobacteria on the interferon-gamma response to bacille Calmette-Guérin vaccination in southern England and northern Malawi.
Weir RE; Black GF; Nazareth B; Floyd S; Stenson S; Stanley C; Branson K; Sichali L; Chaguluka SD; Donovan L; Crampin AC; Fine PE; Dockrell HM
Clin Exp Immunol; 2006 Dec; 146(3):390-9. PubMed ID: 17100757
[TBL] [Abstract][Full Text] [Related]
5. Gamma interferon responses induced by a panel of recombinant and purified mycobacterial antigens in healthy, non-mycobacterium bovis BCG-vaccinated Malawian young adults.
Black GF; Weir RE; Chaguluka SD; Warndorff D; Crampin AC; Mwaungulu L; Sichali L; Floyd S; Bliss L; Jarman E; Donovan L; Andersen P; Britton W; Hewinson G; Huygen K; Paulsen J; Singh M; Prestidge R; Fine PE; Dockrell HM
Clin Diagn Lab Immunol; 2003 Jul; 10(4):602-11. PubMed ID: 12853392
[TBL] [Abstract][Full Text] [Related]
6. Mucosal bacille calmette-Guérin vaccination of humans inhibits delayed-type hypersensitivity to purified protein derivative but induces mycobacteria-specific interferon-gamma responses.
Hoft DF; Brown RM; Belshe RB
Clin Infect Dis; 2000 Jun; 30 Suppl 3():S217-22. PubMed ID: 10875787
[TBL] [Abstract][Full Text] [Related]
7. Monocyte response receptors in BCG driven delayed type hypersensitivity to tuberculin.
Strapagiel D; Kasztalska K; Druszczyńska M; Kowalewicz-Kulbat M; Vrba A; Matusiak A; Chmiela M; Rudnicka W
Folia Histochem Cytobiol; 2008; 46(3):353-9. PubMed ID: 19056540
[TBL] [Abstract][Full Text] [Related]
8. Persistence of the immune response induced by BCG vaccination.
Weir RE; Gorak-Stolinska P; Floyd S; Lalor MK; Stenson S; Branson K; Blitz R; Ben-Smith A; Fine PE; Dockrell HM
BMC Infect Dis; 2008 Jan; 8():9. PubMed ID: 18221509
[TBL] [Abstract][Full Text] [Related]
9. The PPD-specific T-cell clonal response in UK and Malawian subjects following BCG vaccination: a new repertoire evolves over 12 months.
Bennett AR; Gorak-Stolinska P; Ben-Smith A; Floyd S; de Lara CM; Weir RE; Lalor MK; Makamo K; Msiska GK; Crampin AC; Fine PE; Dockrell HM; Beverley PC
Vaccine; 2006 Mar; 24(14):2617-26. PubMed ID: 16414159
[TBL] [Abstract][Full Text] [Related]
10. Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in northern Malawi.
Black GF; Dockrell HM; Crampin AC; Floyd S; Weir RE; Bliss L; Sichali L; Mwaungulu L; Kanyongoloka H; Ngwira B; Warndorff DK; Fine PE
J Infect Dis; 2001 Aug; 184(3):322-9. PubMed ID: 11443558
[TBL] [Abstract][Full Text] [Related]
11. Immune Responses Following BCG Immunization of Infants in Uganda and United Kingdom Are Similar for Purified Protein Derivative but Differ for Secretory Proteins of
Mawa PA; Hasso-Agopsowicz M; Lubyayi L; Nabakooza G; Nakibuule M; Blitz R; Dun L; Govind A; Kaleebu P; Webb EL; Elliott AM; Dockrell HM; Cose S; Smith SG
Front Immunol; 2021; 12():637114. PubMed ID: 33815390
[No Abstract] [Full Text] [Related]
12. Kinetic analysis of Mycobacterium tuberculosis-specific cytokine production by PBMC in adults after BCG vaccination.
Nabeshima S; Murata M; Yamaji K; Chong Y; Nomoto M; Hayashi J
J Infect Chemother; 2005 Feb; 11(1):18-23. PubMed ID: 15729483
[TBL] [Abstract][Full Text] [Related]
13. Mycobacterium tuberculosis PPD-induced immune biomarkers measurable in vitro following BCG vaccination of UK adolescents by multiplex bead array and intracellular cytokine staining.
Smith SG; Lalor MK; Gorak-Stolinska P; Blitz R; Beveridge NE; Worth A; McShane H; Dockrell HM
BMC Immunol; 2010 Jul; 11():35. PubMed ID: 20609237
[TBL] [Abstract][Full Text] [Related]
14. Tuberculin-purified protein derivative-, MPT-64-, and ESAT-6-stimulated gamma interferon responses in medical students before and after Mycobacterium bovis BCG vaccination and in patients with tuberculosis.
Johnson PD; Stuart RL; Grayson ML; Olden D; Clancy A; Ravn P; Andersen P; Britton WJ; Rothel JS
Clin Diagn Lab Immunol; 1999 Nov; 6(6):934-7. PubMed ID: 10548589
[TBL] [Abstract][Full Text] [Related]
15. PPD induced in vitro interferon gamma production is not a reliable correlate of protection against Mycobacterium tuberculosis.
Elias D; Akuffo H; Britton S
Trans R Soc Trop Med Hyg; 2005 May; 99(5):363-8. PubMed ID: 15780343
[TBL] [Abstract][Full Text] [Related]
16. Broad heparin-binding haemagglutinin-specific cytokine and chemokine response in infants following Mycobacterium bovis BCG vaccination.
Smith SG; Lecher S; Blitz R; Locht C; Dockrell HM
Eur J Immunol; 2012 Sep; 42(9):2511-22. PubMed ID: 22653733
[TBL] [Abstract][Full Text] [Related]
17. Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity.
Fine PE; Sterne JA; Pönnighaus JM; Rees RJ
Lancet; 1994 Nov; 344(8932):1245-9. PubMed ID: 7967984
[TBL] [Abstract][Full Text] [Related]
18. Tuberculosis prevention: where do we go from here?
Warndorff DK
Afr Health; 1996 Nov; 19(1):21-2. PubMed ID: 12291917
[TBL] [Abstract][Full Text] [Related]
19. Variability between countries in cytokine responses to BCG vaccination: what impact might this have on protection?
Dockrell HM; Smith SG; Lalor MK
Expert Rev Vaccines; 2012 Feb; 11(2):121-4. PubMed ID: 22309659
[No Abstract] [Full Text] [Related]
20. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group.
Lancet; 1996 Jul; 348(9019):17-24. PubMed ID: 8691924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
